Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling.

Source:http://linkedlifedata.com/resource/pubmed/id/19943223

Download in:

View as

General Info

PMID
19943223